GALECTIN THERAPEUTICS INC. (GALT) Operating income 2016–2025
GALECTIN THERAPEUTICS INC. (GALT) annual operating income history from SEC filings — each fiscal year as reported.
-$20.1MFY2025 · since FY2016: -$21.5M → -$20.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.1M | +52.7% |
| FY2024 | -$42.4M | -11.5% |
| FY2023 | -$38.1M | +0.7% |
| FY2022 | -$38.4M | -27.1% |
| FY2021 | -$30.2M | -28.7% |
| FY2020 | -$23.4M | -74.5% |
| FY2019 | -$13.4M | +1.2% |
| FY2018 | -$13.6M | +16.3% |
| FY2017 | -$16.2M | +24.4% |
| FY2016 | -$21.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GALT financial trends
GALT RevenueGALT Net incomeGALT Net marginGALT Gross profitGALT Gross marginGALT Operating marginGALT Operating cash flowGALT Free cash flowGALT Capital expendituresGALT Return on equityGALT Stock buybacksGALT Dividends paidGALT Total assetsGALT Total liabilitiesGALT Shareholders’ equityGALT overview →